Arch Therapeutics Inc (OTC:ARTH)

Tuesday, May 3, 2016 | Web News
Disclosure: GeoInvesting is providing this information for your edification and in no way has any affiliation with any promoters and/or newsletters disseminating information on ARTH, nor is...
Monday, July 15, 2013 | Web News
Disclosure: GeoInvesting is providing this information for your edification and in no way has any affiliation with any promoters and/or newsletters disseminating information on ARTH, nor is...
Thursday, July 11, 2013 | Web News
Disclosure: GeoInvesting is providing this information for your edification and in no way has any affiliation with any promoters and/or newsletters disseminating information on ARTH, nor is...
See All Research...

About Arch Therapeutics, Inc. (OTCQB: ARTH) Arch Therapeutics, Inc. (OTCQB: ARTH) is a medical device company developing a novel approach to stop bleeding (hemostasis) and control leaking (sealant) during surgery and trauma care. Arch's goal is to develop and commercialize products based on our innovative technology platform that make surgery and interventional care faster and safer for patients. Arch's flagship development stage product candidate known as AC5(TM) is being designed to elegantly achieve hemostasis in minimally invasive and open surgical procedures.

Last updated July 11, 2013


Market Data powered by QuoteMedia. Terms of Use